Will I feel anything wearing your pads?

Yes and no. Some women reported feeling “airy” down there and some don’t feel anything! What you will notice, however, is that TOM pads are much less humid feeling compared to all the other pads. There is always a chance you could feel irritation while wearing any kind of feminine pad. TOM, even with its added protection may still irritate the skin due to friction via movement. If this occurs, stop using TOM pads until you feel like you’re ready to use pads again. If anything more serious occurs, we advise to stop use and see a doctor.

Will any powder be inhaled?

Absolutely not! The filter on the oxygenator-capsule is made using the same N95-grade filter we use to filter the air. It simply does not allow particles of that size to pass through.

Why not tampons?

We believe we should go with nature and not against it; at least until a better solution is discovered. Here are four other reasons:
1) Hormone-Disrupting Herbicides.
“The vast majority ‒ 85 percent ‒ of tampons, cotton, and sanitary products tested in a new Argentinian study contained glyphosate, the key ingredient in Monsanto’s Roundup herbicide, ruled a likely carcinogen by the World Health Organization.” (Source: https://www.rt.com/usa/319524-tampons-cotton-glyphosate-monsanto/)
Glyphosate is a known endocrine aka hormone disruptor. “An endocrine disruptor is a chemical that either mimics or blocks hormones and disrupts the body’s normal functions. This disruption can happen through altering normal hormone levels, halting or stimulating the production of hormones, or interacting directly with the organ the hormone was meant to regulate. Because hormones work at very small doses, endocrine disruption can occur from low-dose exposure to hormonally active chemicals. Low doses over long periods of time may lead to very serious illnesses.” (Source: http://sustainablepulse.com/wp-content/uploads/GMO-health-1.pdf)
The question now: Is the added freedom and comfort worth the infections, odor, mood swings, or possibly even cancer?
2) Tampons are associated with causing many unnecessary problems.
Tampons are associated with a greater increase in Bacterial vaginosis (infecting over 640,000 people a year), Toxic Shock Syndrome (causing multiple deaths per year), and yeast infections (infects up to 3 out of 4 women some point in their lives),
We believe this is due to tampons forcing the menstrual blood to be trapped within the body when nature wants it to come out. As we’ve said before, vaginal pH is generally acidic, but during menstruation, the internal pH rises due to the alkalinity of the blood. Keeping the alkaline blood inside provides just the right conditions for the “bad” bacteria and yeast to multiply in numbers, while the “good” lactobacillus bacteria which thrives in the usual acidic vaginal environment slowly get outnumbered.
That being said, there are pros and cons to each choice. Adding our technology to the traditional feminine pad helps relieve many of the complaints that were typically associated with them.
3) Dryness. Tampons by their very nature absorb everything it can, which can dry you out. It’ll trap the bad bacteria that your body is trying to get rid of, and stop the waste fluids in its tracks.
4) Leftovers. Tampons absorb blood and bacteria for the most part; menstruation involves shedding the outer lining of the uterus. However, the uterine tissue that is supposed to be expelled by the body at that given time is not, as tampons clog it up, allowing the flesh, yeast, bacteria, and blood to be trapped for hours at a time. When you change tampons, there is always a possibility leftover tissue and tampon material stays inside the vagina (tampons materials are often loosely bound to help with absorption), causing an unnatural balance in your personal vaginal ecosystem.

Where can we offer comments or suggestions?

Right here!
We would love to hear from our community! We will continue  to explore ways to improve our products! Believe me when I say: nobody gets anything perfect on the first try. We are here to work with you to tailor our product to our customer’s specific needs, so if anything is missing or unsatisfactory, please don’t be upset, we will work hard to fix any issues you bring to light!
Feel free to take our survey here: <a href=”https://goo.gl/forms/ObFg0QCmDqLi2obd2″ target=”_blank”>Click Here To Take The Survey!</a>
Please send us suggestions to our email at <a href=”mailto:Suggestions@to2m.com” target=”_blank”>Click Here To Email us!</a>
We hope to hear from you soon 🙂

Where are your masks currently manufactured?

Our masks are made at the small city of Anqiu just a bit east of Qingdao, where the 2008 Olympics were held.

What’s contained within your oxygenator capsule?

Each mask contains our patented formula, which includes only food-grade materials that can release trapped oxygen through a special chemical reaction.

What makes your pad so special?

We have created the first feminine pad in the world to provide a steady release of pure oxygen upon use. This means your monthly experience is going to be a lot more comfortable! Another thing we’ve designed into our pad is to make our technology slightly acid forming, to closely mimic the normal vaginal pH (3.8-4.5), this adds another layer of protection by destroying the environment which candida and common BV bacterial strains love, all while helping preserve the positive ratio of the beneficial lactobacillus bacteria. Bacterial Vaginosis and other infections often cause the vaginal pH to rise above pH 4.5. That is the type of environment that bacteria thrive on. We are here to make their new home, less habitable. Also, oxygen has bee shown to help slow or kill existing anaerobic bacteria. Obligate anaerobic microbes generally can tolerate no longer than 15 minutes of oxygen exposure. Allowing you to wear the pad for longer durations with enhanced comfort. However, we still suggest changing your pad based on your usual frequency or at least every 4 hours for better hygiene!

What if the oxygen runs out, can I still wear the pad?

The oxygen may run out at some point, but generally, it’ll last the entire duration of use if not much more. When it does run out, you can switch a pad or continue wearing it as you would a regular pad! There might not be any more oxygen being generated, however even at this point, there are still many advantages versus a traditional pad, such as the acidic nature of our pads which help stunt the growth of microbes even without oxygen!

What Do I Do If The Pad Is Damaged?

If the pad is damaged in any way, please dispose of the pad and use a new one!

The package I have is damaged. Are the masks still safe to use?

We highly recommend to dispose any damaged packaging or products, and to use a new one. Your health comes first! We would never encourage you to use a product that jeopardizes your safety.

Scented or unscented?

Our pads generate oxygen to fight odor-causing bacteria before it has a chance to grow, therefore our pads do not require added scented material!

Is your unique material eco-friendly?

Yes, our patented materials can actually be used to improve soil conditions and help the living conditions of certain ocean life!

Is your material safe?

Yes, Absolutely! We only use food-grade materials! People have ingested food-grade varieties of our material with no problem at all. However, we strongly advise against touching or ingesting it; seriously, DON’T DO IT! It could cause severe irritation if not handled properly, especially when inhaled or if it gets in the eyes. You wouldn’t want to get salt or chili in your eye or lungs, even though it’s perfectly safe to ingest!

Is oxygen harmful to the skin/vulva?

Quite the opposite actually! Oxygen is known to stimulate the body’s natural healing mechanism. It has antimicrobial, anti-inflammatory properties and stimulates collagen production. Oxygen is extremely beneficial for our skin, in fact, it is used to help burn victims recover from their wounds much faster. Our good bacteria, the mighty lactobacillus, actually produces hydrogen peroxide (a weak oxidizer) to help protect women (or itself) from the overgrowth of harmful alkalizing microbes.

Is it reusable?

Yes, it is reusable for as long as the filters aren’t fully clogged with pollutants, which can generally be worn for around 8 hours in a heavily polluted area. For surgical use, however, it is advisable to use a new mask each time you take it off, since the risk of spreading bacteria or viruses increases.

I need to order a large amount for my company/organization. Can I do this through you, or do I go through a distributor?

Both would work! You can contact us directly for the most up-to-date information regarding orders. We recommend going through our “Contact Us” page. Fill out the form properly and name the subject line: Large Order Inquiry.

How should I dispose of the pads after use?

We recommend wrapping the used pad in the wrapper, and properly disposing it in the trash. Do not flush any contents down the toilet!

How much oxygen can each mask generate?

Each mask contains enough of our unique formula to generate up to 500 mL of pure oxygen.

How long can I use it for?

This depends on the environmental conditions, as well your specific use for the mask. For example, if you are using the mask in a heavily polluted environment, the duration of effective use will be decreased. When the mask gets clogged with pollutants, it slowly becomes more difficult to breathe through the filtration materials.

How does the skin-tone balancing work? When will I see results? How much does it balance? Is it permanent? And is it potentially harmful like other balancing products such as creams? Why would I want to balance my skin-tone?

Summary: No, when used properly, it is not potentially harmful like other products, as the only thing extra (compared to a normal pad) interacting with the vulva area is oxygen, which is usually naturally present in the atmosphere, so it is very very safe. Oxygen is known to penetrate deep enough into the skin to reach melanin (skin pigment). Double bonds reflect more light wavelengths, which results in us seeing the darker or reddish hue on our reproductive organs. The oxygen we generate disassembles the double bond, leaving a single bonded “colorless” melanin. The amount of skin-tone balancing generally is achieved rather quickly within days or weeks (depending on the frequency of use), though some may never experience it at all. All the current users have reported reaching at most an equal or balanced skin-tone as other parts of the body. If you’ve ever had your hair bleached with Hydrogen Peroxide, then you’ve experienced this double bond disassembling effect! Remember, oxygen in its gaseous state, even in its pure form, is incredibly safe for the skin and even beneficial for extensive burn wounds! Skin tone balancing effect may vary for each woman depending various situations! The balancing effect is not permanent, it merely disassembles the double bond needed for color into a single bond, and if reassembled into a double bond, the color will reappear. The amount of time it takes to reappear varies from person to person, as the main contributor of the pheomelanin hue is due to activation by your sex hormones! If you would not like the skin-tone balancing effect, these pads may not be for you.
To be clear, we sincerely believe that NOBODY has to change the way they are and we have zero intention of shaming anyone or making anyone insecure about their skin-tone. We know that our delicate areas do not have to be changed in any way! We believe our bodies are made perfect. However, as you may know, tons of women (even men!) actually go through rounds of laser treatment and resort to carcinogenic lightening creams/ointments just to brighten that area of their body! We have received tons of feedback from women saying they really appreciate that factor of our pads. Oxygen does a lot of great things for us; evening out the skin tone is just one of the benefits that naturally come with it! We are providing not only a safe alternative, as the only thing promoting skin tone balancing is pure oxygen, but we are also providing it in a gentle and convenient way! And to be perfectly honest, without putting this effect front and center, it would be misleading to the customers who try our products. However subtle the effect may be, we rather not hide the fact that oxygen might have this effect on the skin. To me, honesty is more important than appealing to everyone. We hope you would understand where I’m coming from. Advertise or not, the effect may occur. I do apologize for making it seem like that’s what we wanted to emphasize.
More detailed version of how the skin-tone balancing works:
The skin has many layers, the first outer layer is called the Epidermis. This layer is about 0.13mm thick and contains the melanocytes which produce mainly two types of melanin, which are the skin pigments. The second layer of skin is the Dermis has a depth starting from approximately 0.14mm and ending at 1.1mm. Under normal conditions, atmospheric oxygen can supply the upper skin layers to a depth of 0.25–0.40 mm. which means that the oxygen will have an opportunity to interact with the pigmented melanins.
The two main melanin pigments are:
Eumelanin, (a black/brownish hued pigment ) which is more susceptible to oxidation and the cleaving of the double bonds (double bonds absorb visible light, hence the dark color). Once the double bond is broken by oxygen it leaves only a single bond, then the light is no longer absorbed and appears colorless to us.
The second and more stable of the bunch, Pheomelanin, is a reddish hue. This is the main type found in reproductive organs, nipples, and lips. Therefore, it’s not that those areas are darker, but rather redder. Pheomelanin can survive longer in the presence of oxygen compared to Eumelanin, but it too will eventually give way to the cleaving of the bonds and lose its color.
Evidence suggests that using hydrogen peroxide to bleach the skin (and hair!) is bad, as it causes blood to avoid flowing to the applied areas (capillary embolism), while the acidic nature of the solution could irritate skin and it causes too strong of an oxidizing effect. Hydrogen peroxide is harmful because in contact with metal ions it forms more damaging radicals, and itself peroxidizes protein residues (thiols for instance) thus modifying them and stressing the cell out. Elsewhere, it interferes with redox signaling and energy production, and itself can act as a signaling molecule. We do not recommend using hydrogen peroxide to bleach skin.
Biologically, oxygen is much more sensitive in its actions, and so its ‘damaging effect’ is more context dependent. For example, it may take years for a metal pipe to rust when exposed to air, but only a day when exposed to H2O2. Inside the body, catalase is a protein evolved as a defense mechanism, which our body’s cells and “good” lactobacillus bacteria contain and generate, while the majority of bad bacterias do not. The catalase simply speeds up the H2O2 > O2 conversion. In that sense, the damaging effect of H2O2 is decreased. Actually, Hydrogen peroxide (oxygen) is produced by our good lactobacillus and helps kill off surrounding pathogenic “bad” bacteria, as those bad bacteria don’t have an innate catalase defense mechanism.
*Disclaimer: TOM does not take any responsibility for the effects that Oxygen may have on the skin tone.

How does it work?

The oxygenator-capsule requires water and/or carbon dioxide to start releasing the bound oxygen. Our technology allows us to literally transform the unfavorable conditions brought about by water vapors and carbon dioxide, and turn them into something beneficial! The result is a much drier and more comfortable mask.

Does your mask really generate oxygen?

Yes! Our mask is attached to a special oxygenator-capsule, which starts generation when you exhale CO2 and/or when moisture is present within the capsule.

Does the oxygen technology cause leakages?

Never! We carefully calculated the amount of oxygen each pad will release to provide adequate protection while preventing leakages.

Does the oxygen technology affect the absorbency?

Absolutely not! We strictly adhere to the standard absorbency ranges for feminine pads. In fact, our material actually helps increase the absorption levels!

Do your pads have wings?

Yes! We believe the wings play an essential role in helping slippage prevention. We have tried many wing iterations and found that the current version is the most effective.

Do you have multiple sizes and absorbencies?

We currently offer a regular and overnight pad. We are excited to add more variations to our product line very soon.

Do you have a list of scientific references?

Yes definitely! References are provided below!
Madigan M, Martinko J, ed. (2005). Brock Biology of Microorganisms (11th ed.). Prentice Hall. ISBN 0-131-44329-1.
Mader JT, Calhoun J (1996). Bone, Joint, and Necrotizing Soft Tissue Infections. In: Baron’s Medical Microbiology (Baron S et al., eds.) (4th ed.). Univ of Texas Medical Branch. (via NCBI Bookshelf) ISBN 0-9631172-1-1.
Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy.Cochrane Database Syst Rev. 2013 Jan 31. 1:CD000262. [Medline].
Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983 Jan. 74(1):14-22. [Medline].
Schuyler JA, Mordechai E, Adelson ME, Sobel JD, Gygax SE, Hilbert DW. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis. Diagn Microbiol Infect Dis. 2015 Oct 8. [Medline].
Tabrizi SN, Fairley CK, Bradshaw CS, Garland SM. Prevalence of Gardnerella vaginalis and Atopobium vaginae in virginal women. Sex Transm Dis. 2006 Nov. 33(11):663-5. [Medline].
Patterson JL, Girerd PH, Karjane NW, Jefferson KK. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol. 2007 Aug. 197(2):170.e1-7. [Medline]. [Full Text].
Fredricks DN, Fiedler TL, Thomas KK, Oakley BB, Marrazzo JM. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol. 2007 Oct. 45(10):3270-6. [Medline]. [Full Text].
Meriwether KV, Rogers RG, Craig E, Peterson SD, Gutman RE, Iglesia CB. The effect of hydroxyquinoline-based gel on pessary-associated bacterial vaginosis: a multicenter randomized controlled trial. Am J Obstet Gynecol. 2015 Nov. 213 (5):729.e1-9. [Medline].
Payne SC, Cromer PR, Stanek MK, Palmer AA. Evidence of African-American women’s frustrations with chronic recurrent bacterial vaginosis. J Am Acad Nurse Pract. 2010 Feb. 22(2):101-8. [Medline].
Marrazzo JM, Fiedler TL, Srinivasan S, et al. Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis. J Infect Dis. 2012 May 15. 205(10):1580-8. [Medline]. [Full Text].
Coughlin G, Secor M. Bacterial vaginosis: update on evidence-based care. Adv Nurse Pract. 2010 Jan. 18(1):41-4, 53. [Medline].
Alcaide ML, Chisembele M, Malupande E, Arheart K, Fischl M, Jones DL. A cross-sectional study of bacterial vaginosis, intravaginal practices and HIV genital shedding; implications for HIV transmission and women’s health. BMJ Open. 2015 Nov 9. 5 (11):e009036. [Medline].
Thurman AR, Kimble T, Herold B, et al. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity. AIDS Res Hum Retroviruses. 2015 Nov. 31 (11):1139-52. [Medline].
Schwiertz A, Taras D, Rusch K, Rusch V. Throwing the dice for the diagnosis of vaginal complaints?. Ann Clin Microbiol Antimicrob. 2006 Feb 17. 5:4. [Medline]. [Full Text].
Mohanty S, Sood S, Kapil A, Mittal S. Interobserver variation in the interpretation of Nugent scoring method for diagnosis of bacterial vaginosis. Indian J Med Res. 2010 Jan. 131:88-91. [Medline].
West B, Morison L, Schim van der Loeff M, et al. Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in The Gambia. Sex Transm Dis. 2003 Jun. 30(6):483-9. [Medline].
Reid G, Burton J, Hammond JA, Bruce AW. Nucleic acid-based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food. 2004 Summer. 7(2):223-8. [Medline].
Masson L, Arnold KB, Little F, et ak. Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.Sex Transm Infect. 2015 Oct 28. [Medline].
Abramovici A, Lobashevsky E, Cliver SP, Edwards RK, Hauth JC, Biggio JR. Quantitative polymerase chain reaction to assess response to treatment of bacterial vaginosis and risk of preterm birth. Am J Perinatol. 2015 Oct. 32 (12):1119-25. [Medline].
Ya W, Reifer C, Miller LE. Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol. 2010 Aug. 203(2):120.e1-6. [Medline].
De Backer E, Verhelst R, Verstraelen H, et al. Antibiotic susceptibility of Atopobium vaginae. BMC Infect Dis. 2006 Mar 16. 6:51. [Medline]. [Full Text].
Avonts D, Sercu M, Heyerick P, Vandermeeren I, Meheus A, Piot P. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis. 1990 Jan-Mar. 17(1):23-9. [Medline].
Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol. 1990 Aug. 163(2):510-4. [Medline].
Berardi-Grassias L, Roy O, Berardi JC, Furioli J. Neonatal meningitis due to Gardnerella vaginalis. Eur J Clin Microbiol Infect Dis. 1988 Jun. 7(3):406-7. [Medline].
Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis. 2006 Feb 1. 193(3):336-45. [Medline].
Bump RC, Buesching WJ 3rd. Bacterial vaginosis in virginal and sexually active adolescent females: evidence against exclusive sexual transmission. Am J Obstet Gynecol. 1988 Apr. 158(4):935-9. [Medline].
Carney FE. Hemophilus vaginalis septicemia. Obstet Gynecol. 1973 Jan. 41(1):78-9. [Medline].
Catlin BW. Gardnerella vaginalis: characteristics, clinical considerations, and controversies. Clin Microbiol Rev. 1992 Jul. 5(3):213-37. [Medline]. [Full Text].
Chen KC, Amsel R, Eschenbach DA, Holmes KK. Biochemical diagnosis of vaginitis: determination of diamines in vaginal fluid. J Infect Dis. 1982 Mar. 145(3):337-45. [Medline].
Embree J, Caliando JJ, McCormack WM. Nonspecific vaginitis among women attending a sexually transmitted diseases clinic. Sex Transm Dis. 1984 Apr-Jun. 11(2):81-4. [Medline].
Eschenbach DA. Bacterial vaginosis and anaerobes in obstetric-gynecologic infection. Clin Infect Dis. 1993 Jun. 16 Suppl 4:S282-7. [Medline].
Eschenbach DA, Hillier S, Critchlow C, Stevens C, DeRouen T, Holmes KK. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 1988 Apr. 158(4):819-28. [Medline].
Ezzell JH Jr, Many WJ Jr. Gardnerella vaginalis: an unusual case of pyogenic liver abscess. Am J Gastroenterol. 1988 Dec. 83(12):1409-11. [Medline].
Gravett MG, Hummel D, Eschenbach DA, Holmes KK. Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol. 1986 Feb. 67(2):229-37. [Medline].
Hallen A, Pahlson C, Forsum U. Bacterial vaginosis in women attending STD clinic: diagnostic criteria and prevalence of Mobiluncus spp. Genitourin Med. 1987 Dec. 63(6):386-9. [Medline]. [Full Text].
Hay PE, Morgan DJ, Ison CA, et al. A longitudinal study of bacterial vaginosis during pregnancy. Br J Obstet Gynaecol. 1994 Dec. 101(12):1048-53. [Medline].
Hedges SR, Barrientes F, Desmond RA, Schwebke JR. Local and systemic cytokine levels in relation to changes in vaginal flora. J Infect Dis. 2006 Feb 15. 193(4):556-62. [Medline].
Hill LV. Anaerobes and Gardnerella vaginalis in non-specific vaginitis. Genitourin Med. 1985 Apr. 61(2):114-9. [Medline]. [Full Text].
Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis. 1993 Jun. 16 Suppl 4:S273-81.[Medline].
Hodge TW Jr, Levy CS, Smith MA. Disk space infection due to Gardnerella vaginalis. Clin Infect Dis. 1995 Aug. 21(2):443-5. [Medline].
Holst E, Wathne B, Hovelius B, Mardh PA. Bacterial vaginosis: microbiological and clinical findings. Eur J Clin Microbiol. 1987 Oct. 6(5):536-41. [Medline].
Joesoef MR, Wiknjosastro G, Norojono W, et al. Coinfection with chlamydia and gonorrhoea among pregnant women and bacterial vaginosis. Int J STD AIDS. 1996 Jan-Feb. 7(1):61-4. [Medline].
Johnson AP, Boustouller YL. Extra-vaginal infection caused by Gardnerella vaginalis. Epidemiol Infect. 1987 Apr. 98(2):131-7. [Medline]. [Full Text].
Jones BM, Geary I, Alawattegama AB, Kinghorn GR, Duerden BI. In-vitro and in-vivo activity of metronidazole against Gardnerella vaginalis, Bacteroides spp. and Mobiluncus spp. in bacterial vaginosis.J Antimicrob Chemother. 1985 Aug. 16(2):189-97. [Medline].
Josey WE, Campbell WG Jr. Vaginitis emphysematosa. A report of four cases. J Reprod Med. 1990 Oct. 35(10):974-7. [Medline].
Klebanoff MA, Andrews WW, Yu KF, et al. A pilot study of vaginal flora changes with randomization to cessation of douching. Sex Transm Dis. 2006 Oct. 33(10):610-3. [Medline].
Legrand JC, Alewaeters A, Leenaerts L, Gilbert P, Labbe M, Glupczynski Y. Gardnerella vaginalis bacteremia from pulmonary abscess in a male alcohol abuser. J Clin Microbiol. 1989 May. 27(5):1132-4.[Medline]. [Full Text].
Leighton PM, Bulleid B, Taylor R. Neonatal cellulitis due to Gardnerella vaginalis. Pediatr Infect Dis. 1982 Sep-Oct. 1(5):339-40. [Medline].
Lugo-Miro VI, Green M, Mazur L. Comparison of different metronidazole therapeutic regimens for bacterial vaginosis. A meta-analysis. JAMA. 1992 Jul 1. 268(1):92-5. [Medline].
Martius J, Eschenbach DA. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity–a review. Arch Gynecol Obstet. 1990. 247(1):1-13. [Medline].
Martius J, Krohn MA, Hillier SL, Stamm WE, Holmes KK, Eschenbach DA. Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol. 1988 Jan. 71(1):89-95. [Medline].
McCormack WM, Hayes CH, Rosner B, et al. Vaginal colonization with Corynebacterium vaginale (Haemophilus vaginalis). J Infect Dis. 1977 Dec. 136(6):740-5. [Medline].
McDonald HM, O’Loughlin JA, Vigneswaran R, Jolley PT, McDonald PJ. Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial. Obstet Gynecol. 1994 Sep. 84(3):343-8. [Medline].
Mengel MB, Berg AO, Weaver CH, et al. The effectiveness of single-dose metronidazole therapy for patients and their partners with bacterial vaginosis. J Fam Pract. 1989 Feb. 28(2):163-71. [Medline].
Nilsson U, Hellberg D, Shoubnikova M, Nilsson S, Mardh PA. Sexual behavior risk factors associated with bacterial vaginosis and Chlamydia trachomatis infection. Sex Transm Dis. 1997 May. 24(5):241-6.[Medline].
Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991 Feb. 29(2):297-301. [Medline].[Full Text].
Pheifer TA, Forsyth PS, Durfee MA, Pollock HM, Holmes KK. Nonspecific vaginitis: role of Haemophilus vaginalis and treatment with metronidazole. N Engl J Med. 1978 Jun 29. 298(26):1429-34. [Medline].
Rein MF. Vulvovaginitis and cervicitis. Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000. 1218-1235.
Sadhu K, Domingue PA, Chow AW, Nelligan J, Cheng N, Costerton JW. Gardnerella vaginalis has a gram-positive cell-wall ultrastructure and lacks classical cell-wall lipopolysaccharide. J Med Microbiol. 1989 Jul. 29(3):229-35. [Medline].
Schnadig VJ, Davie KD, Shafer SK, Yandell RB, Islam MZ, Hannigan EV. The cytologist and bacterioses of the vaginal-ectocervical area. Clues, commas and confusion. Acta Cytol. 1989 May-Jun. 33(3):287-97.[Medline].
Schwebke JR, Hillier SL, Sobel JD, McGregor JA, Sweet RL. Validity of the vaginal gram stain for the diagnosis of bacterial vaginosis. Obstet Gynecol. 1996 Oct. 88(4 Pt 1):573-6. [Medline].
Soper DE, Bump RC, Hurt WG. Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol. 1990 Sep. 163(3):1016-21; discussion 1021-3. [Medline].
Spiegel CA. Bacterial vaginosis. Clin Microbiol Rev. 1991 Oct. 4(4):485-502. [Medline]. [Full Text].
Spiegel CA. Gardnerella vaginalis and Mobiluncus Species. Mandell GL, Bennett JE, Dolin R, eds.Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000. 2383-2386.
Spiegel CA, Amsel R, Holmes KK. Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol. 1983 Jul. 18(1):170-7. [Medline]. [Full Text].
Sturm AW. Gardnerella vaginalis in infections of the urinary tract. J Infect. 1989 Jan. 18(1):45-9.[Medline].
Swedberg J, Steiner JF, Deiss F, Steiner S, Driggers DA. Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis. JAMA. 1985 Aug 23-30. 254(8):1046-9. [Medline].
Thomason JL, Gelbart SM, Anderson RJ, Walt AK, Osypowski PJ, Broekhuizen FF. Statistical evaluation of diagnostic criteria for bacterial vaginosis. Am J Obstet Gynecol. 1990 Jan. 162(1):155-60. [Medline].
Venkataramani TK, Rathbun HK. Corynebacterium vaginale (Hemophilus vaginalis) bacteremia: clinical study of 29 cases. Johns Hopkins Med J. 1976 Sep. 139(3):93-97. [Medline].
Vontver LA, Eschenbach DA. The role of Gardnerella vaginalis in nonspecific vaginitis. Clin Obstet Gynecol. 1981 Jun. 24(2):439-60. [Medline].
Watson RA. Gardnerella vaginalis: genitourinary pathogen in men. Urology. 1985 Mar. 25(3):217-22.[Medline].
Abbai NS, Reddy T, Ramjee G. Prevalent bacterial vaginosis infection – a risk factor for incident sexually transmitted infections in women in Durban, South Africa. Int J STD AIDS. 2015 Nov 3. [Medline].

Can TOM pads treat or cure my BV or Yeast Infections?

NO. TOM pads are not meant to treat or cure anything. Our technology was designed to bring a comfortable defense to the surface of your skin and the pad environment by disrupting the conditions which certain bacterium like to live. We do this by dramatically increasing oxygen levels, as well as lowering pH to similar levels found naturally in healthy women. BV and yeast infections are caused by more than just an unbalanced pH and oxygen-free environments, it’s more of a systemic issue arising from poor food choices such as excess sugars, exogenous or synthetic hormones, too much stress, and not getting enough sleep.

Are your products tested on animals?

We do not, and never will, endorse testing on animals.

Are your masks N95 certified?

Our mask are made using N95-grade materials; however, we are not yet certified. We are currently undergoing the process of receiving the NIOSH-certification. We’re not stopping there though! We are aiming to exceed all FDA regulations, cGMP regulations, OSHA requirements, as well as meeting the CDC guidelines for bacterial infections.

Are your masks manufactured in a cleanroom?

Yes. We have achieved our goal of obtaining the strict ISO 6 classification and the U.S. General Service Administration’s standards known as FS209E. We will continue to maintain these high standards for the safety of our consumers.

Are they manufactured in a cleanroom?

Yes. We follow the BS 5295 Class 2 Cleanroom Standards!

Are there multiple sizes available?

Yes, there are 2 sizes to choose from: regular and small.

Are there any downsides to your pad?

None! We are proud to bring to market such a unique and life-changing product. We’re certain that it will help make your life a bit easier during that tough time of the month!

Are the masks safe?

Yes! The materials we use are made using the industry standards for N95 Respirator masks and has been thoroughly tested for human-use. We source each of our materials through known and trusted suppliers who are adamant about providing high-quality materials. Our manufacturing process is taken very seriously and we manufacture in a cleanroom to ensure no contamination occurs. We use precision ultrasound machinery to securely fasten our filtration layer to our oxygenator-capsule, so absolutely no powder will leak during the manufacturing process.